JPMorgan Chase & Co. Buys 66,747 Shares of Core Laboratories Inc. (NYSE:CLB)

JPMorgan Chase & Co. raised its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 161.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 108,028 shares of the oil and gas company's stock after purchasing an additional 66,747 shares during the period. JPMorgan Chase & Co. owned 0.23% of Core Laboratories worth $1,870,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of the stock. Jane Street Group LLC lifted its position in Core Laboratories by 53.8% in the third quarter. Jane Street Group LLC now owns 71,989 shares of the oil and gas company's stock worth $1,334,000 after buying an additional 25,189 shares during the last quarter. Barclays PLC grew its holdings in Core Laboratories by 288.2% during the 3rd quarter. Barclays PLC now owns 83,570 shares of the oil and gas company's stock valued at $1,549,000 after purchasing an additional 62,042 shares during the last quarter. Geode Capital Management LLC raised its position in Core Laboratories by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company's stock worth $19,521,000 after purchasing an additional 7,721 shares during the period. Tidal Investments LLC lifted its stake in Core Laboratories by 1.7% in the third quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company's stock worth $813,000 after purchasing an additional 716 shares during the last quarter. Finally, Confluence Investment Management LLC boosted its position in shares of Core Laboratories by 0.4% during the fourth quarter. Confluence Investment Management LLC now owns 136,359 shares of the oil and gas company's stock valued at $2,360,000 after buying an additional 599 shares during the period. 97.81% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CLB. StockNews.com lowered Core Laboratories from a "hold" rating to a "sell" rating in a research note on Friday. Citigroup upgraded Core Laboratories from a "sell" rating to a "neutral" rating and lifted their target price for the stock from $15.00 to $16.00 in a research report on Wednesday, March 12th. Finally, Stifel Nicolaus cut their price target on shares of Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a report on Tuesday, April 15th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. According to data from MarketBeat, Core Laboratories has a consensus rating of "Hold" and an average target price of $15.75.

Core Laboratories Trading Down 4.6 %

CLB traded down $0.55 during trading on Monday, hitting $11.31. 478,231 shares of the stock were exchanged, compared to its average volume of 392,352. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32. The firm has a 50 day simple moving average of $13.98 and a 200 day simple moving average of $17.16. The firm has a market cap of $528.20 million, a price-to-earnings ratio of 17.14, a P/E/G ratio of 0.99 and a beta of 1.99. Core Laboratories Inc. has a 1 year low of $10.14 and a 1 year high of $25.13.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. The firm had revenue of $123.59 million for the quarter, compared to analysts' expectations of $125.09 million. During the same quarter in the prior year, the business posted $0.19 EPS. The business's quarterly revenue was down 4.7% on a year-over-year basis. As a group, equities analysts expect that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th will be given a $0.01 dividend. The ex-dividend date of this dividend is Monday, May 5th. This represents a $0.04 annualized dividend and a dividend yield of 0.35%. Core Laboratories's payout ratio is presently 6.78%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.